Historical record - last NADAC effective date: 11/22/2023
Product Information
AMLODIPINE-ATORVAST 5-20 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $2.1717 per EA under NDC 43598031990. Its NADAC has been published 499 times since May 14, 2014.
FDA first approved this application on Mar 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 20 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598031990
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/22/2023
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203874FDA Approved
3/7/2014
TE Code
AB
On Market Since
3/17/2014
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 5-20 MG has been published 499 times since May 14, 2014, and over the history we have for it it has declined 65.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1717 per EA |
|---|---|
| All-time high | $6.6622 (Oct 15, 2014) |
| All-time low | $1.1297 (Oct 19, 2022) |
| Median price | $3.1470 |
| Average price | $3.5996 |
| Largest weekly change | +57.2% (Sep 22, 2021) |
| Weeks tracked | 499 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+10.0%
5Y
+8.8%
All
-65.0%
Last surveyed Nov 29, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-20 MG, manufactured by Dr. Reddy's Laboratories Inc., is $2.1717 per EA (NDC 43598031990), effective Nov 29, 2023.
How has the price of AMLODIPINE-ATORVAST 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-20 MG has declined 65.0%. It has been tracked across 499 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-20 MG?
Since May 14, 2014, the NADAC for AMLODIPINE-ATORVAST 5-20 MG has ranged from a low of $1.1297 (Oct 19, 2022) to a high of $6.6622 (Oct 15, 2014), with a median of $3.1470 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-20 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 5-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 5-20 MG?
AMLODIPINE-ATORVAST 5-20 MG (NDC 43598031990) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.